{"name":"Axogen Corporation","slug":"axogen-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPQ2tVRkI0cm5DbkNBR2FpUDg0RHpyb0VNVHpoaDYxdHJXQ2lIZE5EenUxTWIyRW5wYU1xTENoRUdiTGRLTUtVWjNDN3k2WVhtUzhycVVxbVdQd2pwV1I2em9WYTJsNDZiMHNoYUdSX1VzZ1JmdVkyb0ltM2cxa0NIeFRNZ2pLbE9LNmJ0UEQtYlVyRFZOSzlGYl95NVc1aTBVQmZPbHZGZ2tEdUlTUEE?oc=5","date":"2026-02-24","type":"deal","source":"The Motley Fool","summary":"HighMark Wealth Management Buys 158,855 Shares of Axogen Stock - The Motley Fool","headline":"HighMark Wealth Management Buys 158,855 Shares of Axogen Stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPLW5wXzhtSlRqVTF3OUp4dlFCdG1oakgwN1JpdmRxZVZwempwMmx4Y21acmNIR3JteThUcWpkNFFubTIxR0hteGlieHpzMHpmTmgyR3pva1FjLUJPNFR2Tk5YLThmSHpQTEdlWjNPeE9EM1M5SXJmeWFVNGFRb0YzaTBHOThkYXBxSVdla08zZFZVMmtySkhPcUVDckdQSTdZdktNc0MtcUxjaGRZTHEyaG1ZSFo1akFHbVFVVUtLbUNoZ1hSaF9mWWVsSkQtanNtRGV6UlhpLUpoQQ?oc=5","date":"2026-02-24","type":"earnings","source":"GlobeNewswire","summary":"Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewswire","headline":"Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPMkJDbVpkdmtWRmlNVEpIUEw4UVd1TVFNR3c1LUhEQ01XWkY0NFd5cWxkby1jQnllenFBc3o1Z21EajZjVEJRYnVSM2NlQ3lyQ2xwZFBqNkdpSjM0ZE93U0duQXlLVG40TllWNUYycVNVMlB4azZ4TnB5U0RIcWxRY1F5Y2ZSOXpQNTZzMlp3VW84R2RpNmdMNWpkaU12REdyX3FsVUJJcEtodw?oc=5","date":"2026-01-21","type":"pipeline","source":"Stock Titan","summary":"Axogen plans $85M stock sale to repay loan and fund operations - Stock Titan","headline":"Axogen plans $85M stock sale to repay loan and fund operations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPc1BCRTRYdGhHSWo3ZXNWZFh6ZkVTeE9qQUs2TU5uNWtNckpzTWN2SGdnTzFqTG1lOU00bDhLZ0RsTWNYbEszMmtCa2s1R0luVDFjaUJuTjdORTNtR0tObV82cXZwNDJYX0YzTExKRXFEUUdTbC1TM0FUSjJ5MEdwR2wwb29lcEZHQ1Z2QWNUT2RsZWFvVF8xTVU4SktpZG11dFhvS2c4UjFwSTlNVDlEYXN2bGdYZVpxaEhzay01SjVuMGVBam9RUGJwb21mSXFBOE9YZFVSRTNkTGo1cWItSFhDaERNU2k3UzBfNjdEVQ?oc=5","date":"2026-01-12","type":"earnings","source":"GlobeNewswire","summary":"Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 - GlobeNewswire","headline":"Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQa2hBdjAwZ1F1TTB6Y3ZsbFd1Qzg4T1hpUjJ6LUhkN2R6cHllTjdPTkpPMzZ6djAtTGZ4X2NDb0hCd2tvMF9qYjVHUHlUYVE0QmRZd3Y0MHR5Q2xjR3RkaGMwZUlXcnRGTTRxNGhFbkNCc0J2OHk5Z1REVkNjTXgzR0xXTzlWSlVEdnB6QnBuNC1fSnVtZDJZMXVnRGEwaXg2UWxvcDZ2aDBZdk1GZTZ6QQ?oc=5","date":"2025-12-04","type":"regulatory","source":"reuters.com","summary":"FDA approves Axogen's nerve repair graft - reuters.com","headline":"FDA approves Axogen's nerve repair graft","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE1PdHRta21rbEJGQmUxejRnazFwNXhGa3A4ckJjTE1WZzByNWhOQUcyUG1vVlV3UHktWTU5UGRBeUJIbGNNTXdtUEpnU1hLNTZYN1NqWi1KR2xScDVuT0xnUk5oM3JTY2tf?oc=5","date":"2025-12-04","type":"regulatory","source":"MarketBeat","summary":"AxoGen (AXGN) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"AxoGen (AXGN) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFA4Z09Fc19pZkhpUTN5THQ1aFNORVVhRXVKUkhRV1hEY3RNeXVDNU1OWWt2blF3NlJKcncxYkxOazZIQXhNSklVdU1VXzFhSXJFd3FrTmFR?oc=5","date":"2025-12-03","type":"pipeline","source":"reuters.com","summary":"AxoGen Inc - reuters.com","headline":"AxoGen Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQNjdVTi1HaUF5TmtSOTlIY1QwY2VDNXRaRTN4ejVGZFlEaUEwYmhBdlg5SDNUaWhUUlplQVRqMDFEY0QyZFZ5ZW1JRUVqOWhsdW5UQkVFdXJVN184MzJpbGluclhPVjBiZnhwQTZrS2VFNTloejJSREFqMDUwMzB1NlJBbjBIb0NuajIzbkM0ZUo1R3hoM1dz?oc=5","date":"2025-12-02","type":"regulatory","source":"BioCentury","summary":"FDA’s docket holds 16 more PDUFA dates by year-end - BioCentury","headline":"FDA’s docket holds 16 more PDUFA dates by year-end","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPOTVBRWJDRVlhaVNpYnhOVDhrSkxJY1ZhQXU4QzZnNVZwTmZ1NVJoZmFyQ3dNUTVWS29MU3FvUmNlUVBHV2RBQU1ldGoxRWNkUFhEUjVWUVAtYk5ZZmR0M29XdUo4VDliV1hPMzBlV0pyTXhhMVh5dnR4aTFVb2pyUXE2bk9yYS1OVFFpbmV3cTYwTTRjUkFwMXA1ZFNEUHJVYXduWndZci1pSmpPaURyRGMtVkktMGM?oc=5","date":"2025-12-01","type":"regulatory","source":"Seeking Alpha","summary":"Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen (NASDAQ:AXGN) - Seeking Alpha","headline":"Avance Nerve Graft FDA Verdict Approaches, Why Investors Are Watching Axogen (NASDAQ:AXGN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQMmxUMGI3ckU5d0p4U0NDdVZaVW0yTGlKN0tzdzNRcERMYkYySExRa1p4WXhlQndGRnh4T0NBQS1Qb0lRYmRPbWc2N2hzSjlmUFpNRDNjRWhNN09ZUWRjTGItX3gzRGN0aktTQ1pydGtmbUthNHJoblNGZUV5TVZsdGRMNEszdjdRdWNtdA?oc=5","date":"2025-07-30","type":"pipeline","source":"Yahoo Finance","summary":"Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight - Yahoo Finance","headline":"Global Amniotic Membrane Market Poised for Extraordinary Growth at a CAGR of ~7% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQemhDY0dPbGtoYVoyOHZycHduUF9rMjZ6MV9YdDJCdkJNSEZ5dUw1TEVHUUtCNUxqZURTSkUwSmdzUWwwYzhBTE90V1lqMW1LSzRmcG1acUIxOHlQWHphQ3UyZXBIUGZlN2ZpOXNJUHNRTjlZN2dUbW90QmNESHVqS1BNcTQxSHBReS1oWGlfVnpGRG9JbnFKR3UtQmFXb3FXX3E1UDJzaENxdVRxNC1QNnBEblVVYklEZzlQYUNLd25ybHRTd09zVDlZVmFkQUdUOTllbGxNSXp0NVpMZU11cUtHS1NtbE1pa2ZhT3B1ZWVSMlhvLWh0NWZvUlFRcWEySTdYenlHM2FSVzJzd1HSAZMCQVVfeXFMTTRVWlUtcnpmTGhSZGFldjUtWHU4RUF5WVM3MG5hZjFXSzgwTHJIV05iWkVIUmN4dDdNRjBwLXN1cEpUQXFmTWxiS2tweDVWSjRFQ2xkOUlhRzlqZHdUaVRTcTg3N2lqZ1FSeENqSDBlbkxJS3dnZmYxOE5xM1ZUcm1ES0dDVHkxRjNuOXpDNDhNSGZsOW5YZ05oX3VhLUM4cjZ2dE5kS3RMY0liQ2tMazFneUFVZVp1d0RiSllfZU9SbDJVbEI2N3pDczhtVmNnLXhFV19XN0FrUVZwdzlINjdVODVDalphdFhPSUZMenJuZkhXYVRfMF94anFYOWVZbElOXzlJVHhFbnpyak5KTjFOaU0?oc=5","date":"2024-09-09","type":"regulatory","source":"ET Pharma","summary":"Axogen completes submission process for its Biologics License Application to US FDA for Avance Nerve Graft - ET Pharma","headline":"Axogen completes submission process for its Biologics License Application to US FDA for Avance Nerve Graft","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNZjRvMmdGWTNiTEhldnJ5OUJHbWc2a3p1SjRRS1duQ0RESmdkbkRrUXlZVFQ4LTVyeXRNcWFCQVFpUTlsTG8yVGNOMG1GdElrZVpnczNFQmtoLTQwYTJ6Z0M1UlBmUlVWRFlNYm9CaUg1N0phUnRNVHdrQ1B2bmNBWmZaVTY?oc=5","date":"2023-04-17","type":"pipeline","source":"ryortho.com","summary":"Marc Began Is AxoGen’s New EVP and General Counsel - ryortho.com","headline":"Marc Began Is AxoGen’s New EVP and General Counsel","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}